These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Recinos VR, Tyler BM, Bekelis K, Sunshine SB, Vellimana A, Li KW, Brem H. Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548 [Abstract] [Full Text] [Related]
23. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea. Hank NC, Shapiro JR, Scheck AC. BMC Cancer; 2006 Jan 04; 6():2. PubMed ID: 16393339 [Abstract] [Full Text] [Related]
24. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Kitamura I, Kochi M, Matsumoto Y, Ueoka R, Kuratsu J, Ushio Y. Cancer Res; 1996 Sep 01; 56(17):3986-92. PubMed ID: 8752168 [Abstract] [Full Text] [Related]
25. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line. Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY, Xie SD, Qi ST. J Neurol Sci; 2016 Aug 15; 367():101-6. PubMed ID: 27423571 [Abstract] [Full Text] [Related]
26. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Rocha CR, Kajitani GS, Quinet A, Fortunato RS, Menck CF. Oncotarget; 2016 Jul 26; 7(30):48081-48092. PubMed ID: 27344172 [Abstract] [Full Text] [Related]
27. Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model. Zhang X, Guo M, Shen L, Hu S. Photodiagnosis Photodyn Ther; 2014 Dec 26; 11(4):603-12. PubMed ID: 25449156 [Abstract] [Full Text] [Related]
28. Antiglioma activity of GoPI-sugar, a novel gold(I)-phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivo. Jortzik E, Farhadi M, Ahmadi R, Tóth K, Lohr J, Helmke BM, Kehr S, Unterberg A, Ott I, Gust R, Deborde V, Davioud-Charvet E, Réau R, Becker K, Herold-Mende C. Biochim Biophys Acta; 2014 Aug 26; 1844(8):1415-26. PubMed ID: 24440405 [Abstract] [Full Text] [Related]
29. Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells. Sun H, Zheng X, Zhou Y, Zhu W, Ou Y, Shu M, Gao X, Leng T, Qiu P, Yan G. Steroids; 2013 Oct 26; 78(10):1041-5. PubMed ID: 23831782 [Abstract] [Full Text] [Related]
30. Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties. Lian S, Shi R, Huang X, Hu X, Song B, Bai Y, Yang B, Dong J, Du Z, Zhang Y, Jia J, Ma N, Guo G, Wang M. Oncol Rep; 2016 Aug 26; 36(2):984-90. PubMed ID: 27279152 [Abstract] [Full Text] [Related]
31. Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling. Lan T, Zhao Z, Qu Y, Zhang M, Wang H, Zhang Z, Zhou W, Fan X, Yu C, Zhan Q, Song Y. Oncotarget; 2016 Aug 23; 7(34):55555-55571. PubMed ID: 27487130 [Abstract] [Full Text] [Related]
35. Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells. Oliveira KA, Dal-Cim T, Lopes FG, Ludka FK, Nedel CB, Tasca CI. Mol Neurobiol; 2018 Feb 15; 55(2):1509-1523. PubMed ID: 28181188 [Abstract] [Full Text] [Related]
36. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B. Oncogene; 2007 Jan 11; 26(2):186-97. PubMed ID: 16819506 [Abstract] [Full Text] [Related]
37. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Dai X, Ma C, Lan Q, Xu T. Biofabrication; 2016 Oct 11; 8(4):045005. PubMed ID: 27725343 [Abstract] [Full Text] [Related]
38. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Günther W, Pawlak E, Damasceno R, Arnold H, Terzis AJ. Br J Cancer; 2003 Feb 10; 88(3):463-9. PubMed ID: 12569392 [Abstract] [Full Text] [Related]
39. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma. Kessler T, Sahm F, Blaes J, Osswald M, Rübmann P, Milford D, Urban S, Jestaedt L, Heiland S, Bendszus M, Hertenstein A, Pfenning PN, Ruiz de Almodóvar C, Wick A, Winkler F, von Deimling A, Platten M, Wick W, Weiler M. Oncotarget; 2015 Oct 13; 6(31):31050-68. PubMed ID: 25682871 [Abstract] [Full Text] [Related]
40. Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression. Pan SJ, Wu YB, Cai S, Pan YX, Liu W, Bian LG, Sun B, Sun QF. Biochem Biophys Res Commun; 2015 Mar 13; 458(3):476-482. PubMed ID: 25680464 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]